Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion type Assertion NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_head.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion description "[Activating extrinsic apoptotic pathways targeting death receptors (DR) using agonistic antibodies or TNF-related apoptosis-inducing ligand (TRAIL) is promising for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_provenance.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion evidence source_evidence_literature NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_provenance.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion SIO_000772 23833311 NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_provenance.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion wasDerivedFrom befree-20150227 NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_provenance.
- NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_assertion wasGeneratedBy ECO_0000203 NP804320.RAj3B9SD215c9qsqF2Sl-sqY1y1ULLoaYqpcJAxppfMTM130_provenance.